You are here: Welcome to the MPKB » Welcome to the MPKB » Science behind Marshall Paradigm » Science behind olmesartan (Benicar) » Olmesartan (Benicar) and kidney disease
Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
home:protocol:olmesartan:kidney_disease [08.13.2019] – [Elevated kidney values tend to be temporary] sallieqhome:protocol:olmesartan:kidney_disease [08.13.2019] – [Benefits of olmesartan for patients with kidney disease] sallieq
Line 49: Line 49:
  
 Once patients activate the [[home:pathogenesis:innate_immunity|innate immune system]] with olmesartan and begin rapidly killing the Th1 pathogens, the resulting immunopathology causes a rise in bacterial death, the effects of which are finally high enough to show up on lab tests. Once patients activate the [[home:pathogenesis:innate_immunity|innate immune system]] with olmesartan and begin rapidly killing the Th1 pathogens, the resulting immunopathology causes a rise in bacterial death, the effects of which are finally high enough to show up on lab tests.
-===== Benefits of olmesartan for patients with kidney disease =====+===== Olmesartan benefits patients with kidney disease =====
  
 According to a 2008 commentary appearing in //Nature//: According to a 2008 commentary appearing in //Nature//:
home/protocol/olmesartan/kidney_disease.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.